KA-EX Launches RTD Creatine Beverage With Push-Cap Technology

Why It Matters

The innovation removes a long‑standing efficacy barrier for RTD creatine, opening a new growth segment in sports nutrition and giving athletes a convenient, potent performance drink.

Key Takeaways

• First RTD creatine drink uses push‑cap to keep potency
• Separates Creapure until consumption, preventing degradation to creatinine
• Contains 3 g creatine, 3.5 g EAAs, 1 g citrulline, caffeine
• Retail price $7.99 per bottle; sachets $14.99 (7) or $49.99 (30)

Pulse Analysis

The sports‑nutrition market has long been hampered by the chemical instability of creatine in liquid form, forcing most brands to offer powders that require on‑site mixing. KA‑EX’s Creatine EAA+ Booster sidesteps this limitation with its VICAP push‑cap, a patented delivery system that isolates Creapure—a 99.9% pure creatine monohydrate—until the instant the consumer opens the bottle. By preventing the conversion of creatine to inactive creatinine, the drink guarantees that athletes receive the full clinical dose, a claim that differentiates it from generic RTD energy drinks and could set a new benchmark for product efficacy in the functional beverage space.

Beyond the technical breakthrough, the formulation targets a comprehensive performance profile. The inclusion of essential amino acids supports muscle protein synthesis, while L‑citrulline and beetroot extract enhance blood flow and endurance. A modest caffeine dose mirrors a cup of coffee, delivering alertness without the jittery spikes typical of high‑caffeine drinks. Electrolytes and betaine round out the blend, addressing hydration and cellular stress. This all‑in‑one approach aligns with the growing consumer demand for multitasking supplements that simplify pre‑ and intra‑workout routines, potentially expanding the product’s appeal beyond elite athletes to fitness‑focused millennials.

From a market perspective, pricing the RTD at $7.99 positions the booster competitively against premium sports drinks while offering a unique value proposition rooted in scientific validation. If adoption mirrors the success of KA‑EX’s Cortisol Stress Reducer, the brand could capture a sizable share of the expanding RTD functional beverage segment, prompting competitors to explore similar stability‑preserving technologies. The launch signals a shift toward more sophisticated, research‑backed formulations that prioritize efficacy as much as convenience.